DIVIDENDS RANKING

Highest Dividend yield of Pharmaceuticals and Biotechnology stocks




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

09-30-2016

Dividend yield of Pharmaceuticals and Biotechnology companies ordered from highest ( 1.63% average).

Company Dividend Payout Country
GlaxoSmithKline4.87%43.24%UK
Sanofi4.33%53.27%France
AstraZeneca4.00%80.00%UK
Takeda Pharm3.73%177.17%Japan
Orion B3.70%87.25%Finland
AbbVie Inc3.62%66.09%USA
Pfizer3.54%68.18%USA
Novartis (REGD)3.53%32.53%Switzerland
Novo-Nordisk B3.41%66.83%Denmark
Roche Hldgs (GENUS)3.36%66.56%Switzerland
Merck & Co2.95%55.76%USA
Wockhardt2.85%80.92%India
Teva Pharmaceutical2.84%55.36%Israel
Bristol Myers Squibb2.82%144.76%USA
Johnson & Johnson2.71%52.81%USA
Daiichi Sankyo2.69%44.65%Japan
KYORIN Holdings2.54%31.24%Japan
Lilly (Eli) & Co2.54%74.18%USA
Abbott Laboratories2.46%47.27%USA
Amgen Corp2.40%35.97%USA
Eisai2.39%17.21%Japan
Gilead Sciences2.38%13.06%USA
Kaken Pharmaceutical2.31%27.49%Japan
Miraca Holdings2.24%0.00%Japan
Mitsubishi Tanabe Ph2.23%40.37%Japan
Tsumura & Co2.23%35.90%Japan
Otsuka Holdings2.18%56.90%Japan
Grifols S.A. Cl B2.16%13.48%Spain
Recordati2.10%54.55%Italy
Astellas Pharmaceuti2.10%29.82%Japan
Shanghai Pharmaceuti1.86%33.91%China
Sawai Pharmaceutical1.81%27.87%Japan
Santen Pharm1.75%17.85%Japan
Mochida Pharm1.74%33.41%Japan
Medipal Holdings1.72%22.02%Japan
China Medical System1.68%44.90%China
Kissei Pharm1.67%26.89%Japan
Suzuken1.63%18.58%Japan
TORRENT PHARMACEUTIC1.62%23.65%India
China Traditional Ch1.61%31.58%China
UCB Cap1.60%43.48%Belgium and Lux.
Grifols1.60%22.14%Spain
Alfresa Holdings1.60%20.16%Japan
Kyowa Hakko Kirin1.58%31.76%Japan
Shanghai Fosun Pharm1.57%34.23%China
CSL1.54%42.86%Australia
Hisamitsu Pharmaceut1.48%36.11%Japan
Chugai Seiyaku1.43%45.19%Japan
CSPC Pharmaceutical1.42%37.93%China
Ipsen1.36%34.41%France
Ono Pharmaceutical1.35%75.33%Japan
Lonza Grp Ag N1.35%39.78%Switzerland
Shionogi1.32%31.68%Japan
Richter1.30%20.41%Hungary
Sinopharm Group (H)1.29%28.57%China
Novozymes A/S1.20%33.75%Denmark
Chr. Hansen Holding1.19%45.10%Denmark
Rohto Pharmaceutical1.15%23.92%Japan
Hikma Pharmaceutical1.14%30.67%UK
Kalbe Farma1.11%43.74%Indonesia
Merck Kgaa1.09%21.78%Germany
Sino Biopharm (P Chi1.06%25.00%China
Taisho Pharmaceutica0.97%33.56%Japan
Piramal Enterprises0.95%27.18%India
Sumitomo Dainippon P0.92%23.27%Japan
Kobayashi Pharmaceut0.91%27.57%Japan
Actelion Hldg N0.89%24.51%Switzerland
Cadila Healthcare0.83%21.34%India
Divis Laboratories0.77%23.72%India
Zoetis0.73%40.86%USA
Yuhan0.72%16.06%Korea
China National Accor0.70%13.85%China
Dr Reddys Labs0.64%14.40%India
Perrigo Company plc0.63%14.83%USA
Nippon Shinyaku0.57%33.06%Japan
Lupin0.50%14.35%India
Hanmi Science0.43%15.35%Korea
Hanmi Pharmaceutical0.39%11.62%Korea
Shire0.38%14.18%UK
Cipla0.34%10.29%India
Aurobindo Pharmaceut0.29%7.10%India
Glenmark Pharmaceuti0.22%6.79%India
Sun Pharmaceuticals0.13%4.72%India
Qiagen Nv0.00%0.00%Germany
Valeant Pharmaceutic0.00%0.00%Canada
3SBio (P Chip)0.00%0.00%China
Guangzhou Baiyunsha0.00%0.00%China
Luye Pharma Group (P0.00%0.00%China
Genmab0.00%0.00%Denmark
H. Lundbeck0.00%0.00%Denmark
Peptidream0.00%0.00%Japan
Celltrion Inc0.00%0.00%Korea
Aspen Pharmacare Hol0.00%0.00%South Africa
OBI Pharma0.00%0.00%Taiwan
Alexion Pharm0.00%0.00%USA
Alkermes plc0.00%0.00%USA
Allergan0.00%0.00%USA
Alnylam Pharmaceutic0.00%0.00%USA
Biogen0.00%0.00%USA
BioMarin Pharm0.00%0.00%USA
Celgene Corp0.00%0.00%USA
Endo International p0.00%0.00%USA
Illumina Inc0.00%0.00%USA
Incyte0.00%0.00%USA
Jazz Pharmaceuticals0.00%0.00%USA
Mallinckrodt plc0.00%0.00%USA
Medivation0.00%0.00%USA
Mylan N.V.0.00%0.00%USA
Quintiles Transnatio0.00%0.00%USA
Regeneron Phar0.00%0.00%USA
Vertex Pharm0.00%0.00%USA
Adcock Ingram Holdin2.74%88.51%South Africa
Meda A1.57%21.55%Sweden
GlaxoSmithKline Phar1.51%111.59%India

 


 

All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.